Skip to main content
. 2020 May;8(9):605. doi: 10.21037/atm.2020.03.122

Table 2. Clinical characteristics and outcomes of patients infected with CRKP.

Characteristics No./total (%)
Infection types
   Intra-abdominal infection 18/252 (7.14)
   Urinary tract infection 30/252 (11.90)
   Lower respiratory tract infection 209/252 (82.94)
   Bacteremia 23/252 (9.13)
   Meningitis 25/252 (9.92)
   Other infections 3/252 (1.19)
APACHE II Score 20 (4~48)
Septic shock 3/252 (1.19)
Laboratory findings
White blood cell, /mm3
Median (Interquartile range) 13.82 (3.6~88.8)
   Subgroup
    <4,000 (/mm3) 30/252 (11.90)
    >10,000 (/mm3) 151/252 (59.92)
C-reactive protein >10 mg/L 118/252 (46.82)
Procalcitonin
   >2 ng/mL 40/252 (15.87)
Clinical outcomes
   Length of stay, median (interquartile range), days 37.11 (3~730)
   ICU admission 204/252 (80.95)
   Length of ICU stay, median (interquartile range), days 14.44 (1~112)
Discharge disposition
   Home 127/252 (50.540)
   Long-term acute facility 3/252 (1.19)
   Follow-up outpatient 15/252 (5.95)
   Transfer to other hospitals 11/252 (4.37)
Mortality
   In-hospital mortality 59/252 (23.41)
   30 day’s mortality 37/252 (14.68)

CRKP, carbapenem-resistant Klebsiella pneumoniae.